CompuGroup Medical
Synchronizing Healthcare

We promote dialog in the healthcare sector and ensure that costs are saved in a meaningful way. Everyone should benefit from medical progress with the help of IT.

Investor Relations
Career
Contact

Investment highlights

Strong market positions  

Technology leadership

Continuous investments in user experience and interoperability

Recurring revenue share: 74%

Sustainable revenue & EBITDA growth with high margins

Strong cashflow profile

Excellent track record in value enhancing M&A

€1.154 bnRevenues in 2024
€225mAdjusted EBITDA
19%Adjusted EBITDA margin
 

Digitization in healthcare accelerates growth

CompuGroup Medical issues joint reasoned statement recommending shareholders to accept CVC’s public delisting offer

CompuGroup Medical and CVC plan delisting - public delisting offer announced by CVC

Q1/2025: CompuGroup Medical reports slow start into the year